Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-Related Cognitive Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07641114
What this trial is testing

Behavior Change Wheel-Based Music Listening for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients

Who this might be right for
Breast CancerChemotherapy-Related Cognitive Impairment
The First Affiliated Hospital with Nanjing Medical University 90
Testing effectiveness (Phase 2)Study completedNCT01205503
What this trial is testing

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Who this might be right for
Breast CancerNon-Hodgkin's Lymphoma
Mara Chambers 32
Testing effectiveness (Phase 2)Study completedNCT00495703
What this trial is testing

The Activity Intervention for Chemobrain

Who this might be right for
CancerChemotherapyCognitive Impairment
Vanderbilt University Medical Center 64
Not applicableStudy completedNCT04813965
What this trial is testing

Breast Cancer Patients' Cognitive Symptoms After Information About Chemotherapy-Related Cognitive Symptoms

Who this might be right for
Breast CancerCognitive SymptomsCognitive Decline
Radboud University Medical Center 148
Not applicableStudy completedNCT04230863
What this trial is testing

Neuroplasticity-Based Cognitive Remediation for Chemotherapy-Related Cognitive Impairment

Who this might be right for
Cancer SurvivorsChemotherapy-related Cognitive Impairment
Vanderbilt University Medical Center 21
Not applicableLooking for participantsNCT06687291
What this trial is testing

Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer

Who this might be right for
Gastroesophageal Cancer (GC)Postoperative Delirium (POD)Quality of Life (QOL)+6 more
Karolinska Institutet 130
Testing effectiveness (Phase 2)Ended earlyNCT02317783
What this trial is testing

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

Who this might be right for
Breast Cancer
University of Utah 15
Not applicableLooking for participantsNCT05014399
What this trial is testing

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

Who this might be right for
Neoplasm, ColorectalCognitive ImpairmentCognitive Dysfunction+5 more
Joseph McCollom 60
Not applicableStudy completedNCT05909813
What this trial is testing

Individualized Piano Instruction (IPI) for Improving Cognition in Breast Cancer Survivors.

Who this might be right for
Breast CancerChemotherapy-Related Cognitive Impairment
University of Miami 6
Testing effectiveness (Phase 2)UnknownNCT05941598
What this trial is testing

Electroacupuncture for Chemotherapy-Related Cognitive Impairment

Who this might be right for
Chemotherapy-Related Cognitive Impairment
Beijing University of Chinese Medicine 100
Not applicableLooking for participantsNCT05840575
What this trial is testing

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

Who this might be right for
Chemotherapy-Related Cognitive ImpairmentChemotherapeutic ToxicityChemo-brain+7 more
Rigshospitalet, Denmark 100
Large-scale testing (Phase 3)UnknownNCT05595109
What this trial is testing

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Who this might be right for
Breast CancerPeripheral NeuropathyCardiac Toxicities+2 more
Tanta University 56
Post-approval studies (Phase 4)Not Yet RecruitingNCT06508671
What this trial is testing

Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment

Who this might be right for
Chemotherapy-Related Cognitive ImpairmentDL-3-n-butylphthalide
First Hospital of China Medical University 100
Not applicableNot Yet RecruitingNCT07017530
What this trial is testing

Cognitive Training and Exercise for Women With Breast Cancer and Cognitive Impairment

Who this might be right for
Breast Cancer
Universidad de Extremadura 220
Not applicableLooking for participantsNCT02290834
What this trial is testing

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

Who this might be right for
Impaired CognitionChemo-brainBreast Cancer
Massachusetts General Hospital 200
Not applicableUnknownNCT05409248
What this trial is testing

Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors

Who this might be right for
Breast CancerCognitive Decline
Universidad Antonio de Nebrija 120
Not applicableNot Yet RecruitingNCT07165912
What this trial is testing

Effects of a Group Versus Individual Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment

Who this might be right for
Breast Cancer FemalesOncology
University of Salamanca 75
Testing effectiveness (Phase 2)Looking for participantsNCT04520139
What this trial is testing

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

Who this might be right for
Ovarian CancerCognitive Impairment
University of California, Irvine 102
Large-scale testing (Phase 3)Enrolling By InvitationNCT06950190
What this trial is testing

Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)

Who this might be right for
Chemotherapy-related Cognitive Impairment
Ellis Medicine 100
Not applicableUnknownNCT06103318
What this trial is testing

EHealth Interventions for Breast Cancer Cognitive Impairment

Who this might be right for
Breast CancerCognitive Dysfunction
Institut Català d'Oncologia 176
Next Page